CN106212822A - A kind of cancer-resisting health tea - Google Patents
A kind of cancer-resisting health tea Download PDFInfo
- Publication number
- CN106212822A CN106212822A CN201610683938.7A CN201610683938A CN106212822A CN 106212822 A CN106212822 A CN 106212822A CN 201610683938 A CN201610683938 A CN 201610683938A CN 106212822 A CN106212822 A CN 106212822A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- tea
- cancer
- health tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of teas, particularly relate to cancer-resisting health tea.A kind of cancer-resisting health tea, it is made up of the crude drug of following weight parts: Cortex Seu Folium Linderae 12 18 parts, Radix actinidiae valvatae 8 12 parts, Flos Hibisci Mutabilis 46 parts, Radix Codonopsis Lanceolatae 46 parts, Radix Pseudostellariae 8 12 parts, Bulbus Fritillariae Cirrhosae 17 23 parts, Radix Platycodonis 8 12 parts, Radix Apioris Fortunei (Radix Lespedezae Buergeri) 59 parts, Rhizoma Paridis 46 parts, Fructus Jujubae 12 18 parts, Semen Maydis 46 parts, 24 parts of Fructus Cucurbitae moschatae.Cortex Seu Folium Linderae in this formula main component, removing toxic substances and promoting subsidence of swelling, eliminating stasis to stop pain, grey the most vicious, coordinate Radix actinidiae valvatae's removing pathogenic heat from blood and toxic substance from the body, spleen invigorating dries, two medicines and join effect more.The effect of above-mentioned single medicine be combined with each other, and is configured by certain proportion, and by special bubble prescription method, it is evident in efficacy for clinical for the tea finally given.
Description
Technical field
The present invention relates to a kind of teas, particularly relate to cancer-resisting health tea.
Background technology
The most on the market based on general wellness tea, mainly increase the immune health care to anosis crowd and preventive effect.
Real health-care tea with anticancer is the preventive and therapeutic action of phase morning, noon and afternoon three for tumour patient, has the effect of removing toxic substances spleen invigorating.
Its specially good effect is the detumescence of diuresis toxin expelling, and stasis-dispelling and pain-killing effect, clothes can make lump disappear for a long time, and blood stasis degases.The medical knowledge of strong the five internal organs, coordinates
Traditional Chinese medical science traditional idea research handed down from one's ancestors.Cure the disease and first control blood, the theoretical foundation of blood common fault spontaneous recovery, prepare cancer preventing tea, for various swollen
Tumor people, plays beyond thought effect.From more than ten years, clinical discovery patient is administered orally cancer preventing tea, and some patients carry cancer thin
Born of the same parents are the most also survived.The patient of survival has, 1 year 3 years, 5 years, 10 years, and the patient of different tumors, is worth with clinical observation
Research, but the curative effect of existing cancer preventing tea does not reaches the above.
Summary of the invention
The deficiency existed for prior art, it is an object of the invention to provide a kind of curative effect obvious cancer-resisting health tea
Formula.
To achieve these goals, present invention employs following technical scheme:
A kind of cancer-resisting health tea, is made up of the crude drug of following weight parts:
Cortex Seu Folium Linderae 12-18 part, Radix actinidiae valvatae's 8-12 part, Flos Hibisci Mutabilis 4-6 part, Radix Codonopsis Lanceolatae 4-6 part, Radix Pseudostellariae 8-12 part, Bulbus Fritillariae Cirrhosae 17-23
Part, Radix Platycodonis 8-12 part, Radix Apioris Fortunei (Radix Lespedezae Buergeri) 5-9 part, Rhizoma Paridis 4-6 part, Fructus Jujubae 12-18 part, Semen Maydis 4-6 part, Fructus Cucurbitae moschatae 2-4 part.
Preferably, described manufacturing process comprises the following steps:
1) the above-mentioned fine powder that is ground into, tea bag after hybrid filtering, is made；
2) in every for tea bag 90-130g, put into 200-220ml water, with the fire of 88-92 degree, decoct and obtain tea 150-in 10 minutes
160ml。
Compared with prior art, the invention has the beneficial effects as follows: Cortex Seu Folium Linderae in this formula main component, removing toxic substances and promoting subsidence of swelling,
Eliminating stasis to stop pain, grey the most vicious, find through clinical research, brew up, for various oncosises, preventive and therapeutic action can be played,
Effect of neoplasm metastasis can be controlled.Coordinating Radix actinidiae valvatae's removing pathogenic heat from blood and toxic substance from the body, spleen invigorating dries, two medicines and join effect more.Flos Hibisci Mutabilis removing heat from blood,
Removing toxic substances, detumescence, effect energy of toxin expelling, can make internal toxin excrete, and three and join the clinical sight of various tumour patients
Examine, mass reduction can be made, act the effect delaying life.Join Radix Pseudostellariae the moon hereby to mend and Radix Codonopsis Lanceolatae heat-clearing and toxic substances removing.Detumescence and apocenosis.Detumescence
Spleen invigorating, the medical knowledge enriched blood.In prophylaxis of tumours, play beyond thought clinical effectiveness.Join Bulbus Fritillariae Cirrhosae, relieving cough and resolving phlegm lung heat clearing, can promote
Toxin expelling dampness removing effect is higher.Joining Radix Platycodonis has evacuation of pus to subside a swelling, effect of sore-throat relieving.Say from medical knowledge, the theory of lang-QI disease spontaneous recovery, in conjunction with
Radix Apioris Fortunei (Radix Lespedezae Buergeri), protecting liver and expelling toxin, play Liver and kidney strong, the theory of blood spontaneous recovery, then coordinate Rhizoma Paridis, clearing away heat,cooling blood and removing toxin.Then go up
Medicine can lead to heart channel, lung meridian, stomach warp, large intestine channel with joining.Therefrom medical knowledge argumentation, each meridians lead to, and the therapy that all kinds of diseases and ailments can be prevented, red Herba Pelargonii Graveolentis is joined
Closing all medicines to show from pharmacological evaluation, decoct juice has stronger bacteriostasis to influenza A virus；To dysentery bacterium, Salmonella,
Paracolon, bacillus pyocyaneus, staphylococcus aureus, Hemolytic streptococcus cancerous cell all have inhibitory action.Above-mentioned single medicine
Effect be combined with each other, and is configured by certain proportion, and by special bubble prescription method, it is evident in efficacy for clinical for the tea finally given.
Detailed description of the invention
The following specific embodiments of the present invention is to make a detailed explanation.
Embodiment 1
A kind of cancer-resisting health tea, every 110g bag is to be made up of the crude drug of following weight parts:
Cortex Seu Folium Linderae 15g, Radix actinidiae valvatae 10g, Flos Hibisci Mutabilis 5g, Radix Codonopsis Lanceolatae 5g, Radix Pseudostellariae 10g, Bulbus Fritillariae Cirrhosae 20g, Radix Platycodonis 10g, Radix Apioris Fortunei (Radix Lespedezae Buergeri) 7g,
Rhizoma Paridis 5g, Fructus Jujubae 15g, Semen Maydis 15g, Fructus Cucurbitae moschatae 3g.
Described manufacturing process comprises the following steps:
1) the above-mentioned fine powder that is ground into, tea bag after hybrid filtering, is made
2) above-mentioned 110g tea bag is put into 200ml water, with the fire of 90 degree, decoct and obtain tea 150ml in 10 minutes.
The present embodiment is mainly used in anticancer initial stage patient and takes.
Embodiment 2
A kind of cancer-resisting health tea, every 128g bag is to be made up of the crude drug of following weight parts:
Cortex Seu Folium Linderae 18g, Radix actinidiae valvatae 12g, Flos Hibisci Mutabilis 6g, Radix Codonopsis Lanceolatae 6g, Radix Pseudostellariae 12g, Bulbus Fritillariae Cirrhosae 23g, Radix Platycodonis 12g, Radix Apioris Fortunei (Radix Lespedezae Buergeri) 9g,
Rhizoma Paridis 6 parts, Fructus Jujubae 15g, Semen Maydis 5g, Fructus Cucurbitae moschatae 4g.
Preferably, described manufacturing process comprises the following steps:
1) the above-mentioned fine powder that is ground into, tea bag after hybrid filtering, is made；
2) every for tea bag 128g is put into 220ml water, with the fire of 92 degree, decoct and obtain tea 160ml in 10 minutes.
The present embodiment is mainly used in anticancer middle and advanced stage patient and takes, and main dose all increases, and the constant rate of water, fire becomes
After great, decocting time is identical, obtains the tea that drug effect is bigger, and within the equal course for the treatment of, its drug effect plays bigger.
Embodiment 3
A kind of cancer-resisting health tea, every 90g bag is to be made up of the crude drug of following weight parts:
Cortex Seu Folium Linderae 12g, Radix actinidiae valvatae 8g, Flos Hibisci Mutabilis 4g, Radix Codonopsis Lanceolatae 4g, Radix Pseudostellariae 8g, Bulbus Fritillariae Cirrhosae 17g, Radix Platycodonis 8g, Radix Apioris Fortunei (Radix Lespedezae Buergeri) 5g, seven
Leaf YIZHIHUA 5g, Fructus Jujubae 12g, Semen Maydis 5g, Fructus Cucurbitae moschatae 4g.
Preferably, described manufacturing process comprises the following steps:
1) the above-mentioned fine powder that is ground into, tea bag after hybrid filtering, is made；
2) every for tea bag 90g is put into 200ml water, with the fire of 88 degree, decoct and obtain tea 150ml in 10 minutes.
The present embodiment is mainly used in the anti-cancer phase and daily takes.
Effect explanation
The non-treatment just anti-cancer stage uses, it is only necessary to when tea takes the tea that the formula decoction of 150ml embodiment 3 obtains indefinite time
Water.
As the anticancer health-protecting tea for the treatment of, need to take stage by stage.Primary treatment medium and advanced lung cancer, hepatocarcinoma, breast carcinoma, stomach
Cancer, esophageal carcinoma, cervical cancer, intestinal cancer, thyroid carcinoma, lymphatic cancer, initial stage clothes for patients mode is to take joining of 500ml embodiment 1 day
Just decoct the tea obtained, the coolest after decoction after take immediately, it is impossible to placing long-time, the morning, noon and afternoon respectively take one
Secondary, noon one after each meal 200ml tea.In decoction process on the basis of above formula, put crude drug and the 250ml of 5% more
Water, observes after taking continuously 17 to 30 days again.Have in taking a course for the treatment of symptom take a turn for the better or mass reduction, can according to circumstances,
Suitably reducing a day dose, the cycle of taking is 4-6 month.
The patient of middle and advanced stage, after the formula taking embodiment 2 decocts the tea that obtains 17 to 20 days, does not has obvious disease
Shape, its effect has taken a turn for the better, and needs to take the most continuously 6-10 month, is tracked its curative effect observing, if or needed
To be taken can extend to 12-18 month by the stage.
Efficacy evaluation
In taking a course for the treatment of mass reduction, symptom take a turn for the better or cancerous cell without diffusion under control of effectively, after adhering to 6-10 month,
Symptom lump index is normal, for clinical cure.
Clinically by above standard, 100 patients are carried out tracking efficacy evaluation, wherein initial stage cancer patient 50, in
Patient with advanced cancer 50, in the therapeutic process of 6-10 month, cures 17 initial stage cancer patients and 3 middle and terminal cancers is suffered from
Person, 30 initial stage cancer patients and 32 middle and terminal cancer conditions of patients have taken a turn for the better.
Claims (2)
1. a cancer-resisting health tea, it is characterised in that be made up of the crude drug of following weight parts:
Cortex Seu Folium Linderae 12-18 part, Radix actinidiae valvatae's 8-12 part, Flos Hibisci Mutabilis 4-6 part, Radix Codonopsis Lanceolatae 4-6 part, Radix Pseudostellariae 8-12 part, Bulbus Fritillariae Cirrhosae 17-23
Part, Radix Platycodonis 8-12 part, Radix Apioris Fortunei (Radix Lespedezae Buergeri) 5-9 part, Rhizoma Paridis 4-6 part, Fructus Jujubae 12-18 part, Semen Maydis 4-6 part, Fructus Cucurbitae moschatae 2-4 part.
A kind of cancer-resisting health tea the most according to claim 1, it is characterised in that described manufacturing process includes following
Step:
1) the above-mentioned fine powder that is ground into, tea bag after hybrid filtering, is made；
2) in every for tea bag 90-130g, put into 200-220ml water, with the fire of 88-92 degree, decoct and obtain tea 150ml in 10 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610683938.7A CN106212822A (en) | 2016-08-18 | 2016-08-18 | A kind of cancer-resisting health tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610683938.7A CN106212822A (en) | 2016-08-18 | 2016-08-18 | A kind of cancer-resisting health tea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106212822A true CN106212822A (en) | 2016-12-14 |
Family
ID=57553191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610683938.7A Pending CN106212822A (en) | 2016-08-18 | 2016-08-18 | A kind of cancer-resisting health tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106212822A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1242206A (en) * | 1998-07-17 | 2000-01-26 | 吴大胜 | Traditional Chinese herb medicine for treating cancer |
| CN1562088A (en) * | 2003-10-15 | 2005-01-12 | 董柏贤 | Oral adminitration Chinese medicine for treating lung cancer |
| CN102973808A (en) * | 2012-12-25 | 2013-03-20 | 郑定富 | Medicament for treating cancer |
| CN103478351A (en) * | 2013-08-30 | 2014-01-01 | 铜陵市天屏山调味品厂 | Ginger-jujube tea and making method thereof |
| CN103735997A (en) * | 2014-01-23 | 2014-04-23 | 田军 | Traditional Chinese medicine preparation for treating stomach cancer and preparation method |
| CN103749783A (en) * | 2014-01-14 | 2014-04-30 | 廖宣植 | Hibiscus golden camellia tea |
| CN104984020A (en) * | 2015-07-30 | 2015-10-21 | 宁波好口味食品有限公司 | Traditional Chinese medicinal preparation for treating hysteromyoma, and preparation method thereof |
| CN105535657A (en) * | 2016-02-22 | 2016-05-04 | 席新进 | Traditional Chinese medicine composition for treating colon cancer |
-
2016
- 2016-08-18 CN CN201610683938.7A patent/CN106212822A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1242206A (en) * | 1998-07-17 | 2000-01-26 | 吴大胜 | Traditional Chinese herb medicine for treating cancer |
| CN1562088A (en) * | 2003-10-15 | 2005-01-12 | 董柏贤 | Oral adminitration Chinese medicine for treating lung cancer |
| CN102973808A (en) * | 2012-12-25 | 2013-03-20 | 郑定富 | Medicament for treating cancer |
| CN103478351A (en) * | 2013-08-30 | 2014-01-01 | 铜陵市天屏山调味品厂 | Ginger-jujube tea and making method thereof |
| CN103749783A (en) * | 2014-01-14 | 2014-04-30 | 廖宣植 | Hibiscus golden camellia tea |
| CN103735997A (en) * | 2014-01-23 | 2014-04-23 | 田军 | Traditional Chinese medicine preparation for treating stomach cancer and preparation method |
| CN104984020A (en) * | 2015-07-30 | 2015-10-21 | 宁波好口味食品有限公司 | Traditional Chinese medicinal preparation for treating hysteromyoma, and preparation method thereof |
| CN105535657A (en) * | 2016-02-22 | 2016-05-04 | 席新进 | Traditional Chinese medicine composition for treating colon cancer |
Non-Patent Citations (4)
| Title |
|---|
| 杨叔禹等: "《治病救命特效方大全集》", 30 June 2016, 福建科学技术出版社 * |
| 金有景: "《抗癌食药本草（上卷）》", 31 December 1989, 中国食品出版社 * |
| 陈熠: "《肿瘤防治康复全书》", 30 April 1996, 上海人民出版社 * |
| 骆仙芳: "《健康之路从肺开始》", 31 January 2014, 浙江科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520395B (en) | Traditional Chinese medicine composition for treating lung cancer | |
| CN104547525A (en) | Drug composition for NSCLC (Non Small Cell Lung Cancer) prevention and preparation method thereof | |
| CN102526498B (en) | Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof | |
| CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN103263587B (en) | Traditional Chinese medicine preparation for treating toxic and side effects of nasopharyngeal carcinoma after radiotherapy and preparation method thereof | |
| CN111097030A (en) | Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof | |
| CN103908600B (en) | The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method | |
| CN102940815A (en) | Medicine prescription for treating tuberculosis and tuberculous rheumatism | |
| US20200030401A1 (en) | Anticancer pharmaceutical composition and application thereof | |
| CN106212822A (en) | A kind of cancer-resisting health tea | |
| CN105106634A (en) | Traditional Chinese medicine preparation for treating acute appendicitis and application thereof | |
| CN103784689A (en) | Medicinal composition for treating leukemia | |
| CN103877397B (en) | A kind of medicine of radiotherapy injury of lung and preparation method | |
| CN102552619B (en) | Medicine for treating tumor and preparation method thereof | |
| CN103211949B (en) | Traditional Chinese medicine composition for treating gastric diseases of human body as well as preparation method and application thereof | |
| CN103301309B (en) | Traditional Chinese herbal medicine for treating laryngocarcinoma and esophagus cancer | |
| CN106237156A (en) | A kind of Chinese medicine composition treating gastric cancer and preparation method thereof | |
| CN105998538A (en) | Traditional Chinese medicine composition used for tonsillitis | |
| CN105288334A (en) | Gastric cancer treatment medicine for oral administration and preparation method of gastric cancer treatment medicine for oral administration | |
| CN105232661A (en) | Traditional Chinese medicine composition for treating mastitis and preparation method thereof | |
| CN105477555A (en) | Formula of traditional Chinese medicine for treating lung cancer and preparation method thereof | |
| CN105213597A (en) | Yao medicinal composition of a kind of Hepatoma therapy, gastric cancer, intestinal cancer and preparation method thereof | |
| CN105168944A (en) | Traditional Chinese medicinal composition for treating breast cancer and application thereof | |
| CN104258309A (en) | Traditional Chinese medicine composition for treating cancers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161214 |